Literature DB >> 5569251

Inhibition of the intestinal absorption of inorganic and hemoglobin iron by cholestyramine.

F B Thomas, F S McCullough, N J Greenberger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5569251

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  5 in total

Review 1.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

2.  Médication et nutrition chez le coronarien.

Authors:  M De Belder
Journal:  Can Fam Physician       Date:  1979-10       Impact factor: 3.275

3.  Inhibition of iron absorption by cholestyramine. Demonstration of diminished iron stores following prolonged administration.

Authors:  F B Thomas; D Salsburey; N J Greenberger
Journal:  Am J Dig Dis       Date:  1972-03

Review 4.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

5.  Alterations in calcium, magnesium, iron, and zinc metabolism by dietary cholestyramine.

Authors:  D W Watkins; R Khalafi; M M Cassidy; G V Vahouny
Journal:  Dig Dis Sci       Date:  1985-05       Impact factor: 3.199
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.